Trinity Biotech (TRIB) Depreciation and Depletion (2009 - 2024)
Trinity Biotech (TRIB) posted quarterly Depreciation and Depletion of $317000.0 for Q4 2024, up 15750.0% year-on-year from N/an in Q1 2024, and up 121823.08% on a QoQ basis from $260.0 in Q3 2024.
Trinity Biotech (TRIB) Depreciation and Depletion (2009 - 2024) Analysis & Trends
Trinity Biotech (TRIB) has reported Depreciation and Depletion for 8 consecutive years, with $317000.0 the latest figure, recorded in Q4 2024.
- Quarterly Depreciation and Depletion rose 15750.0% year-over-year to $317000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $317359.0 (up 11118.06% YoY) and the FY2025 annual result came in at $1.3 million, up 92.44% from the prior year.
- Depreciation and Depletion climbed to $317000.0 in Q4 2024 per TRIB's latest filing, from $260.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for TRIB reached as high as $478000.0 in Q3 2022 and fell as low as -$65.0 in Q2 2024.
- A 4-year average of $107524.0 and a median of $351.0 in 2023 frame the typical range for Depreciation and Depletion.
- The largest YoY upside for Depreciation and Depletion was 15750.0% in 2024 against a maximum downside of 121.31% in 2024.
- Year by year, Depreciation and Depletion stood at $146000.0 in 2021, then jumped by 210.27% to $453000.0 in 2022, then slumped by 99.56% to $2000.0 in 2023, then surged by 15750.0% to $317000.0 in 2024.
- According to Business Quant data, Depreciation and Depletion over the past three periods registered $317000.0, $260.0, and -$65.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 308.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 89.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 317,000.00 |
| Dec 31, 2024 | 317,000.00 |
| Sep 30, 2024 | 260.00 |
| Sep 30, 2024 | 260.00 |
| Jun 30, 2024 | -65.00 |
| Jun 30, 2024 | -65.00 |
| Mar 31, 2024 | 164.00 |
| Mar 31, 2024 | 164.00 |
| Dec 31, 2023 | 2,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | 173.00 |
| Sep 30, 2023 | 173.00 |
| Jun 30, 2023 | 305.00 |
| Jun 30, 2023 | 305.00 |
| Mar 31, 2023 | 351.00 |
| Mar 31, 2023 | 351.00 |
| Dec 31, 2022 | 453,000.00 |
| Dec 31, 2022 | 453,000.00 |
| Sep 30, 2022 | 478,000.00 |
| Sep 30, 2022 | 478,000.00 |